Logo image of CRON.CA

CRONOS GROUP INC (CRON.CA) Stock Price, Quote, News and Overview

TSX:CRON - Toronto Stock Exchange - CA22717L1013 - Common Stock - Currency: CAD

2.79  -0.07 (-2.45%)

CRON.CA Quote, Performance and Key Statistics

CRONOS GROUP INC

TSX:CRON (5/23/2025, 7:00:00 PM)

2.79

-0.07 (-2.45%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High3.66
52 Week Low2.27
Market Cap1.08B
Shares385.41M
Float200.42M
Yearly DividendN/A
Dividend YieldN/A
PE15.5
Fwd PE24.66
Earnings (Next)08-06 2025-08-06
IPO05-07 2014-05-07


CRON.CA short term performance overview.The bars show the price performance of CRON.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 4 -4 6 8

CRON.CA long term performance overview.The bars show the price performance of CRON.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10 -20

The current stock price of CRON.CA is 2.79 CAD. In the past month the price increased by 8.98%. In the past year, price decreased by -23.14%.

CRONOS GROUP INC / CRON Daily stock chart

CRON.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
BHC.CA BAUSCH HEALTH COS INC 1.17 2.26B
DHT-UN.CA DRI HEALTHCARE TRUST 5.82 711.76M
TLRY.CA TILRAY BRANDS INC N/A 615.32M
GUD.CA KNIGHT THERAPEUTICS INC 115.8 576.86M
WEED.CA CANOPY GROWTH CORP N/A 527.43M
ACB.CA AURORA CANNABIS INC 32.78 413.64M
NGEN.CA NERVGEN PHARMA CORP N/A 366.74M
CPH.CA CIPHER PHARMACEUTICALS INC 19.41 318.20M
HITI.CA HIGH TIDE INC N/A 255.28M
OGI.CA ORGANIGRAM GLOBAL INC N/A 250.36M
TSND.CA TERRASCEND CORP N/A 198.39M
HLS.CA HLS THERAPEUTICS INC N/A 148.03M

About CRON.CA

Company Profile

CRON logo image Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm operates through one segment, which is comprised of operations in Canada and Israel and is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, and Lord Jones. The Spinach brand offers pre-rolls infused with cold-filtered cannabis extract and coated in kief, and all-in-one disposable vapes. The Lord Jones is a hemp-derived cannabidiol (CBD) brand. Its Lord Jones Hash Fusions are a line-up of premium ice water hash infused pre-rolls. This brand also offers vapes and edibles. Its PEACE NATURALS offer Peppermint CBD, a blend of CBD extract, quality medium-chain triglycerides (MCT) oil, and a hint of natural peppermint flavor.

Company Info

CRONOS GROUP INC

4491 Concession Rd 12

TORONTO ONTARIO M5V2G9 CA

CEO: Kurt T. Schmidt

Employees: 459

CRON Company Website

CRON Investor Relations

Phone: 14165040004

CRONOS GROUP INC / CRON.CA FAQ

What is the stock price of CRONOS GROUP INC today?

The current stock price of CRON.CA is 2.79 CAD. The price decreased by -2.45% in the last trading session.


What is the ticker symbol for CRONOS GROUP INC stock?

The exchange symbol of CRONOS GROUP INC is CRON and it is listed on the Toronto Stock Exchange exchange.


On which exchange is CRON.CA stock listed?

CRON.CA stock is listed on the Toronto Stock Exchange exchange.


What is the price forecast or stock price prediction for CRONOS GROUP INC stock?

10 analysts have analysed CRON.CA and the average price target is 3.68 CAD. This implies a price increase of 31.8% is expected in the next year compared to the current price of 2.79. Check the CRONOS GROUP INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is CRONOS GROUP INC worth?

CRONOS GROUP INC (CRON.CA) has a market capitalization of 1.08B CAD. This makes CRON.CA a Small Cap stock.


How many employees does CRONOS GROUP INC have?

CRONOS GROUP INC (CRON.CA) currently has 459 employees.


What are the support and resistance levels for CRONOS GROUP INC (CRON.CA) stock?

CRONOS GROUP INC (CRON.CA) has a support level at 2.72 and a resistance level at 2.97. Check the full technical report for a detailed analysis of CRON.CA support and resistance levels.


Is CRONOS GROUP INC (CRON.CA) expected to grow?

The Revenue of CRONOS GROUP INC (CRON.CA) is expected to grow by 18.44% in the next year. Check the estimates tab for more information on the CRON.CA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy CRONOS GROUP INC (CRON.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CRONOS GROUP INC (CRON.CA) stock pay dividends?

CRON.CA does not pay a dividend.


When does CRONOS GROUP INC (CRON.CA) report earnings?

CRONOS GROUP INC (CRON.CA) will report earnings on 2025-08-06.


What is the Price/Earnings (PE) ratio of CRONOS GROUP INC (CRON.CA)?

The PE ratio for CRONOS GROUP INC (CRON.CA) is 15.5. This is based on the reported non-GAAP earnings per share of 0.18 and the current share price of 2.79 CAD. Check the full fundamental report for a full analysis of the valuation metrics for CRON.CA.


CRON.CA Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to CRON.CA. When comparing the yearly performance of all stocks, CRON.CA is a bad performer in the overall market: 76.96% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CRON.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CRON.CA. While CRON.CA has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CRON.CA Financial Highlights

Over the last trailing twelve months CRON.CA reported a non-GAAP Earnings per Share(EPS) of 0.18. The EPS increased by 285.71% compared to the year before.


Industry RankSector Rank
PM (TTM) 39.68%
ROA 4.29%
ROE 4.64%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%300%
Sales Q2Q%27.57%
EPS 1Y (TTM)285.71%
Revenue 1Y (TTM)33.92%

CRON.CA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 76% to CRON.CA. The Buy consensus is the average rating of analysts ratings from 10 analysts.

For the next year, analysts expect an EPS growth of -144.2% and a revenue growth 18.44% for CRON.CA


Ownership
Inst Owners13.13%
Ins Owners5.48%
Short Float %N/A
Short RatioN/A
Analysts
Analysts76
Price Target3.68 (31.9%)
EPS Next Y-144.2%
Revenue Next Year18.44%